FNY Managed Accounts’s iShares Biotechnology ETF IBB Stock Holding History

FNY Managed Accounts’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30	Closed	-$3K	–	699
2017 Q4	$3K	Buy	+30	New	+$3.21K	﹤0.01%	409
2016 Q4	–	Sell	-6	Closed	-$2.55K	–	145
2016 Q3	$2.55K	Buy	+6	New	+$571	﹤0.01%	365
2016 Q2	–	Sell	-57	Closed	-$8.18K	–	349
2016 Q1	$8.18K	Buy	+57	New	+$5.1K	0.01%	236

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FNY Managed Accounts's IBB Position: Q1 2018 in Review

FNY Managed Accounts sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 4,400 shares — an estimated $469K sold.

FNY Managed Accounts first reported a position in IBB in Q1 2014 and held it in 7 quarters. The position peaked at $472K in Q3 2015. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

FNY Managed Accounts reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 4,400 iShares Biotechnology ETF shares in Q1 2018, an estimated $469K.
FNY Managed Accounts first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 7 quarters.
FNY Managed Accounts's iShares Biotechnology ETF position peaked at $472K in Q3 2015.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.